Back to first-pass browser

First-pass extracted concept

genetic testing

Candidate: concept label2 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Genetic testing is presented as a gastroenterology-relevant clinical approach for hereditary pancreatitis and hereditary gastrointestinal cancer syndromes. It can also subtype disease presentations such as pancreatitis.

Source 1DOIPubMed

Genetic testing provides molecular information used in AML diagnosis and categorization. The abstract links assay development in this area to the updated ELN recommendations.

Source 2DOIPubMed

Resources required

It requires testing of disease-associated genes and clinical interpretation in the context of the gastrointestinal condition and family history.

Source 1DOIPubMed

It requires genetic testing assays, though the abstract does not identify specific technologies or reporting standards.

Source 2DOIPubMed

What problem it solves

It helps distinguish hereditary from idiopathic disease and identify family members at risk.

Source 1DOIPubMed

It supports revised ELN genetic categories by enabling more detailed characterization of AML.

Source 2DOIPubMed

What it does not solve

The abstract does not indicate that genetic testing alone addresses treatment response monitoring or progressive disease assessment.

Source 2DOIPubMed

Alternatives

The abstract does not name a specific alternative testing modality, but contrasts genetic diagnosis with previously undiagnosed or idiopathic classification.

Source 1DOIPubMed

The abstract separately highlights MRD detection as another major assessment axis alongside genetic testing.

Source 2DOIPubMed

Evidence Snippets

Genetics and genetic medicine have been reported to play a role in gastroenterology in several ways, including genetic testing (hereditary pancreatitis and hereditary gastrointestinal cancer syndromes). Genetic testing can also help subtype diseases, such as classifying pancreatitis as idiopathic or hereditary.
Evidence 1Source 1DOIPubMedprovenance
Recent advances ... in the development of assays for genetic testing ... prompted an international panel to provide updated evidence- and expert opinion-based recommendations.
Evidence 2Source 2DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1clinical utilitysupports2026Source 1DOIPubMed

Genetic testing plays a role in gastroenterology including hereditary pancreatitis and hereditary gastrointestinal cancer syndromes.

Claim 2disease subtypingsupports2026Source 1DOIPubMed

Genetic testing can help subtype pancreatitis by classifying it as idiopathic or hereditary.

Claim 3review scope summarysupports2016Source 2DOIPubMed

Recent advances in AML genomics, genetic testing assays, MRD detection assays, and novel antileukemic agents motivated updated ELN recommendations for diagnosis and management in adults.